Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/688526 stock hub

SHA/688526 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/688526is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.9B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/688526

In the news

Latest news · SHA/688526

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.5

P25 17.1P50 24.2P75 37.8

Trailing P/E17.7

P25 23.5P50 41.3P75 83.2

ROE9.3

P25 -0.9P50 4.1P75 8.8

ROIC14.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/688526 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

CNY

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	950
Employees Change	26%
Employees Change Percent	2.81
Enterprise value	CNY 5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE1000042Q8
Last refreshed	2026-05-10
Market cap	CNY 6.9B
Price	CNY 14.88
Price currency	CNY
Rev Per Employee	981,147.51x
Sector	Healthcare
Sic	2834
Symbol	sha/688526
Website	https://www.kqbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.65%
EV Earnings	12.91x
EV/EBIT	13.97x
EV/EBITDA	10.61x
EV/FCF	19.36x
EV/Sales	5.4x
FCF yield	3.76%
Forward P/E	14.52x
P/B ratio	1.6x
P/E ratio	17.72x
P/S ratio	7.41x
PE Ratio3 Y	19.91x
PE Ratio5 Y	22.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	38.62%
EBITDA Margin	50.71%
FCF margin	27.87%
Gross margin	64.71%
Gross Profit	CNY 603.1M
Gross Profit Growth	-0.54%
Gross Profit Growth Q	-9.84%
Gross Profit Growth3 Y	-8.62%
Gross Profit Growth5 Y	-5.93%
Net Income	CNY 389.7M
Net Income Growth	-3.38%
Net Income Growth Q	-26.79%
Net Income Growth Years	1%
Net Income Growth3 Y	-4.98%
Net Income Growth5 Y	-5.76%
Pretax Margin	47.87%
Profit Margin	41.81%
Profit Per Employee	CNY 410,234
Profitable Years	10
ROA	4.75
Roa5y	6.13
ROCE	8.17
ROE	9.26
Roe5y	12.51
ROIC	14.55
Roic5y	20.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-5.31%
Cagr3y	-14.45%
Cagr5y	-16.25%
Div CAGR3	31.29%
EPS Growth	-3.66
EPS Growth Q	-26.09
EPS Growth Years	1
EPS Growth3 Y	-4.67
EPS Growth5 Y	-7.87
FCF Growth	-8.91%
FCF Growth Q	-69.95%
FCF Growth3 Y	-12.95%
FCF Growth5 Y	-5.03%
OCF Growth	-5.17%
OCF Growth Q	-63.96%
OCF Growth3 Y	-8.55%
OCF Growth5 Y	-7.04%
Revenue Growth	-5.1x
Revenue Growth Q	-7.2x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.74x
Revenue Growth5 Y	-1.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.2
Assets	CNY 4.8B
Cash	CNY 1.9B
Current Assets	CNY 3.1B
Current Liabilities	CNY 419.2M
Debt	CNY 6.3M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.02
Equity	CNY 4.3B
Liabilities	CNY 512.2M
Long Term Assets	CNY 1.7B
Long Term Liabilities	CNY 93M
Net Cash	CNY 1.9B
Net Cash By Market Cap	CNY 27.14
Net Cash Growth	40.64%
Net Debt EBITDA	CNY -3.96
Net Debt Equity	CNY -0.43
Net Debt FCF	CNY -7.21
Tangible Book Value	CNY 4.2B
Tangible Book Value Per Share	CNY 9.11
WACC	6.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.42
Inventory Turnover	2.53
Net Working Capital	CNY 812.1M
Quick ratio	5.29
Working Capital	CNY 2.7B
Working Capital Turnover	CNY 0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.64
Dividend Years	5
Dividend Yield	4.3%
Ex Div Date	2025-06-16
Last Dividend	CNY 0.43
Payout Frequency	Annual
Payout Ratio	51.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-5.3%
200-day SMA	16.36
3Y total return	-37.39%
50-day SMA	15.27
50-day SMA vs 200-day SMA	50under200
5Y total return	-58.79%
All Time High	51.11
All Time High Change	-70.89%
All Time High Date	2020-11-24
All Time Low	11
All Time Low Change	35.27%
All Time Low Date	2024-09-18
ATR	0.28
Beta	0.5
Beta1y	0.62
Beta2y	0.69
Ch YTD	-2.49
High	14.94
High52	20.39
High52 Date	2025-08-26
High52ch	-27.02%
Low	14.65
Low52	14.17
Low52 Date	2026-03-23
Low52ch	5.01%
Ma50ch	-2.57%
Price vs 200-day SMA	-9.02%
RSI	48.83
RSI Monthly	44.07
RSI Weekly	40.38
Sharpe ratio	0.01x
Sortino ratio	0.24
Total Return	4.01%
Tr YTD	-2.49
Tr1m	-0.87%
Tr1w	1.57%
Tr3m	-8.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 360M
Operating Income Growth	8.76
Operating Income Growth Q	-18.63
Operating Income Growth3 Y	-5.74
Operating Income Growth5 Y	-8
Operating margin	38.62

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	114,934,949%
Net Borrowing	-1,402,525
Shares Insiders	57.93%
Shares Institutions	3.07%
Shares Out	463,916,483
Shares Qo Q	2.77%
Shares Yo Y	0.29%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 259.7M
Average Volume	2,128,328.65x
Bv Per Share	9.25
CAPEX	CNY -119.2M
Ch1m	-0.87
Ch1w	1.57
Ch1y	-7.81
Ch3m	-8.71
Ch3y	-40.91
Ch5y	-61.74
Ch6m	-7.35
Change	1.16%
Change From Open	0.88
Close	14.71
Days Gap	0.27
Depreciation Amortization	112,650,021
Dollar Volume	22,621,498.6
Earnings Date	2026-08-25
EBIT	CNY 360M
EBITDA	CNY 472.7M
EPS	CNY 0.84
F Score	5
FCF	CNY 259.7M
FCF EV Yield	5.16x
FCF Per Share	CNY 0.56
Financing CF	-183,740,227
Fiscal Year End	December
Founded	2,001
Graham Number	13.22156
Graham Upside	-11.15
Income Tax	CNY 58.3M
Investing CF	-594,532,833
Is Primary Listing	1
Last Earnings Date	2026-04-08
Last Report Date	2026-03-31
Lynch Fair Value	CNY 4.2
Lynch Upside	-71.78
Ma150	16.01
Ma150ch	-7.05%
Ma20	14.89
Ma20ch	-0.09%
Net CF	-401,356,163
Next Earnings Date	2026-08-25
Open	14.75
P FCF Ratio	26.58
P OCF Ratio	18.22
Payment Date	2025-06-16
Position In Range	79.31
Ppne	849,464,593
Price Date	2026-05-08
Price EBITDA	CNY 14.6
Ptbv Ratio	1.63
Relative Volume	0.69x
Revenue	932,090,138x
Tax By Revenue	6.26x
Tax Rate	13.07%
Tr6m	-7.35%
Volume	1,520,262

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/688526 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.3%

$0.64 annual per share

Payout ratio

+51.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+4.0%

Next ex-dividend date: 2025-06-16

Performance

SHA/688526 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/688526?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.1%

Share of float held by funds and institutions

Insider ownership

+57.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

SHA/688526 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.8

Neutral momentum band

Price vs 200-day MA

-9.0%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/688526

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/688526 stock rating?

sha/688526 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/688526 analysis?

The full report lives at /stocks/sha/688526/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/688526?

The latest report frames sha/688526 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/688526 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.